The methylcyclohexane (MCH)-toluene cycle is a promising liquid organic hydride system as a hydrogen carrier. Generally, MCH dehydrogenation has been conducted over Pt-supported catalysts, for which it requires temperatures higher than 623 K because of its endothermic nature. For this study, an electric field was applied to Pt/TiO 2 catalyst to promote MCH dehydrogenation at low temperatures. Selective dehydrogenation was achieved with the electric field application exceeding thermodynamic equilibrium, even at 423 K. With the electric field, "inverse" kinetic isotope effect (KIE) was observed by accelerated proton collision with MCH on the Pt/TiO 2 catalyst. Moreover, Pt/TiO 2 catalyst showed no methane byproduction and less coke formation during MCH dehydrogenation. DRIFTS and XPS measurements revealed that electron donation from TiO 2 to Pt weakened the interaction between catalyst surface and p-coordination of toluene. Results show that the electric field facilitated MCH dehydrogenation without methane and coke by-production over Pt/TiO 2 catalyst. † Electronic supplementary information (ESI) available. See
Oxidative coupling of methane (OCM)
over La
1–
x
M
x
AlO
3−δ
(M = Ca, Sr, Ba;
x
= 0, 0.1, 0.2, 0.3) in an electric
field at low temperature (423 K) was investigated. Among the tested
catalysts, the La
0.7
Ca
0.3
AlO
3−δ
catalyst showed the highest performance in terms of C
2
H
6
+ C
2
H
4
yield (11.1%). Surface
mobile oxygen species (O
2
2–
or O
–
), which were considered as active oxygen species for
the OCM reaction, increased with increasing Ca doping amount, and
thereby the La
0.7
Ca
0.3
AlO
3−δ
catalyst showed the best catalytic activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.